Virtu Financial LLC Homology Medicines, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$0.53 - $1.14 $17,909 - $38,521	33,791 New	33,791 $21,000
Q2 2022 Aug 09, 2022	BUY	$1.39 - $3.12 $24,154 - $54,216	17,377 New	17,377 $34,000
Q1 2021 May 19, 2021	SELL	$9.17 - $14.8 $140,539 - $226,824	-15,326 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$8.92 - $13.29 $43,823 - $65,293	4,913 Added 47.18%	15,326 $173,000
Q1 2018 May 14, 2018	BUY	$18.66 - $18.7 $194,306 - $194,723	10,413 New	10,413 $195,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.